Functional ABCG1 expression induces apoptosis in macrophages and other cell types

Biochimica et Biophysica Acta - Biomembranes

Volumn 1778, Issue 10, 2008, Pages 2378-2387

  Seres, László ^a   Cserepes, Judit ^a   Elkind, N Barry ^a   Törocsik, Dániel ^b   Nagy, László ^b   Sarkadi, Balázs ^a   Homolya, László ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

ABC transporter; Annexin V binding; Atherosclerosis; LXR ligand; Macrophage

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; BENZAMIL; BREAST CANCER RESISTANCE PROTEIN; CASPASE 3; CELL NUCLEUS RECEPTOR; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; NUCLEAR RECEPTOR LXR; PHOSPHATIDYLSERINE; THYROXINE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; ATHEROGENESIS; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN TRANSPORT;

ANIMALS; APOPTOSIS; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; CELL SHAPE; HUMANS; MACROPHAGES; MICE; MONOCYTES; RECOMBINANT FUSION PROTEINS;

EID: 52049088936     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2008.06.010     Document Type: Article

References (81)

1. Kerr J.F., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26 (1972) 239-257
2. Tabas I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler Thromb. Vasc. Biol. 25 (2005) 2255-2264
3. Kockx M.M., and Herman A.G. Apoptosis in atherosclerosis: beneficial or detrimental?. Cardiovasc. Res. 45 (2000) 736-746
4. Geng Y.J., and Libby P. Progression of atheroma: a struggle between death and procreation. Arterioscler Thromb. Vasc. Biol. 22 (2002) 1370-1380
5. Bombeli T., Karsan A., Tait J.F., and Harlan J.M. Apoptotic vascular endothelial cells become procoagulant. Blood 89 (1997) 2429-2442
6. Flynn P.D., Byrne C.D., Baglin T.P., Weissberg P.L., and Bennett M.R. Thrombin generation by apoptotic vascular smooth muscle cells. Blood 89 (1997) 4378-4384
7. Kockx M.M., De Meyer G.R., Muhring J., Jacob W., Bult H., and Herman A.G. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation 97 (1998) 2307-2315
8. Libby P., Geng Y.J., Aikawa M., Schoenbeck U., Mach F., Clinton S.K., Sukhova G.K., and Lee R.T. Macrophages and atherosclerotic plaque stability. Curr. Opin. Lipidol. 7 (1996) 330-335
9. Galis Z.S., Sukhova G.K., Lark M.W., and Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94 (1994) 2493-2503
10. Schrijvers D.M., De Meyer G.R., Kockx M.M., Herman A.G., and Martinet W. Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler Thromb. Vasc. Biol. 25 (2005) 1256-1261
11. Schrijvers D.M., De Meyer G.R., Herman A.G., and Martinet W. Phagocytosis in atherosclerosis: molecular mechanisms and implications for plaque progression and stability. Cardiovasc. Res. 73 (2007) 470-480
12. Mallat Z., Hugel B., Ohan J., Leseche G., Freyssinet J.M., and Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99 (1999) 348-353
13. Greeno E.W., Bach R.R., and Moldow C.F. Apoptosis is associated with increased cell surface tissue factor procoagulant activity. Lab. Invest. 75 (1996) 281-289
14. Kobayashi A., Takanezawa Y., Hirata T., Shimizu Y., Misasa K., Kioka N., Arai H., Ueda K., and Matsuo M. Efflux of sphingomyelin, cholesterol, and phosphatidylcholine by ABCG1. J. Lipid Res. 47 (2006) 1791-1802
15. Cserepes J., Szentpetery Z., Seres L., Ozvegy-Laczka C., Langmann T., Schmitz G., Glavinas H., Klein I., Homolya L., Varadi A., Sarkadi B., and Elkind N.B. Functional expression and characterization of the human ABCG1 and ABCG4 proteins: indications for heterodimerization. Biochem. Biophys. Res. Commun. 320 (2004) 860-867
16. Wang N., Ranalletta M., Matsuura F., Peng F., and Tall A.R. LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL. Arterioscler Thromb. Vasc. Biol. 26 (2006) 1310-1316
17. Vaughan A.M., and Oram J.F. ABCG1 redistributes cell cholesterol to domains removable by high density lipoprotein but not by lipid-depleted apolipoproteins. J. Biol. Chem. 280 (2005) 30150-30157
18. Xie Q., Engel T., Schnoor M., Niehaus J., Hofnagel O., Buers I., Cullen P., Seedorf U., Assmann G., and Lorkowski S. Cell surface localization of ABCG1 does not require LXR activation. Arterioscler. Thromb. Vasc. Biol. 26 (2006) e143-e144 author reply e145
19. Nakamura M., Ueno S., Sano A., and Tanabe H. Polymorphisms of the human homologue of the Drosophila white gene are associated with mood and panic disorders. Mol. Psychiatry 4 (1999) 155-162
20. Croop J.M., Tiller G.E., Fletcher J.A., Lux M.L., Raab E., Goldenson D., Son D., Arciniegas S., and Wu R.L. Isolation and characterization of a mammalian homolog of the Drosophila white gene. Gene 185 (1997) 77-85
21. Kirov G., Lowry C.A., Stephens M., Oldfield S., O'Donovan M.C., Lightman S.L., and Owen M.J. Screening ABCG1, the human homologue of the Drosophila white gene, for polymorphisms and association with bipolar affective disorder. Mol. Psychiatry 6 (2001) 671-677
22. Klucken J., Buchler C., Orso E., Kaminski W.E., Porsch-Ozcurumez M., Liebisch G., Kapinsky M., Diederich W., Drobnik W., Dean M., Allikmets R., and Schmitz G. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 817-822
23. Venkateswaran A., Repa J.J., Lobaccaro J.M., Bronson A., Mangelsdorf D.J., and Edwards P.A. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols. J. Biol. Chem. 275 (2000) 14700-14707
24. Baldan A., Tarr P., Lee R., and Edwards P.A. ATP-binding cassette transporter G1 and lipid homeostasis. Curr. Opin. Lipidol. 17 (2006) 227-232
25. Li A.C., Binder C.J., Gutierrez A., Brown K.K., Plotkin C.R., Pattison J.W., Valledor A.F., Davis R.A., Willson T.M., Witztum J.L., Palinski W., and Glass C.K. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. J. Clin. Invest. 114 (2004) 1564-1576
26. Kennedy M.A., Venkateswaran A., Tarr P.T., Xenarios I., Kudoh J., Shimizu N., and Edwards P.A. Characterization of the human ABCG1 gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein. J. Biol. Chem. 276 (2001) 39438-39447
27. Laffitte B.A., Repa J.J., Joseph S.B., Wilpitz D.C., Kast H.R., Mangelsdorf D.J., and Tontonoz P. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 507-512
28. Nakamura K., Kennedy M.A., Baldan A., Bojanic D.D., Lyons K., and Edwards P.A. Expression and regulation of multiple murine ATP-binding cassette transporter G1 mRNAs/isoforms that stimulate cellular cholesterol efflux to high density lipoprotein. J. Biol. Chem. 279 (2004) 45980-45989
29. Kennedy M.A., Barrera G.C., Nakamura K., Baldan A., Tarr P., Fishbein M.C., Frank J., Francone O.L., and Edwards P.A. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell. Metab. 1 (2005) 121-131
30. Vaughan A.M., and Oram J.F. ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL. J. Lipid. Res. 47 (2006) 2433-2443
31. Wang N., Lan D., Chen W., Matsuura F., and Tall A.R. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 9774-9779
32. Wang X., Collins H.L., Ranalletta M., Fuki I.V., Billheimer J.T., Rothblat G.H., Tall A.R., and Rader D.J. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J. Clin. Invest. 117 (2007) 2216-2224
33. Oram J.F., and Vaughan A.M. ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins. Curr. Opin. Lipidol. 11 (2000) 253-260
34. Lawn R.M., Wade D.P., Garvin M.R., Wang X., Schwartz K., Porter J.G., Seilhamer J.J., Vaughan A.M., and Oram J.F. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J. Clin. Invest. 104 (1999) R25-R31
35. Wang N., and Tall A.R. Regulation and mechanisms of ATP-binding cassette transporter A1-mediated cellular cholesterol efflux. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1178-1184
36. Gelissen I.C., Harris M., Rye K.A., Quinn C., Brown A.J., Kockx M., Cartland S., Packianathan M., Kritharides L., and Jessup W. ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 534-540
37. Jessup W., Gelissen I.C., Gaus K., and Kritharides L. Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages. Curr. Opin. Lipidol. 17 (2006) 247-257
38. Oram J.F., and Vaughan A.M. ATP-binding cassette cholesterol transporters and cardiovascular disease. Circ. Res. 99 (2006) 1031-1043
39. Sarkadi B., Price E.M., Boucher R.C., Germann U.A., and Scarborough G.A. Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J. Biol. Chem. 267 (1992) 4854-4858
40. Telbisz A., Muller M., Ozvegy-Laczka C., Homolya L., Szente L., Varadi A., and Sarkadi B. Membrane cholesterol selectively modulates the activity of the human ABCG2 multidrug transporter. Biochim. Biophys. Acta 1768 (2007) 2698-2713
41. Fu X., Menke J.G., Chen Y., Zhou G., MacNaul K.L., Wright S.D., Sparrow C.P., and Lund E.G. 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J. Biol. Chem. 276 (2001) 38378-38387
42. Liu M.L., Reilly M.P., Casasanto P., McKenzie S.E., and Williams K.J. Cholesterol enrichment of human monocyte/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 430-435
43. Yao P.M., and Tabas I. Free cholesterol loading of macrophages induces apoptosis involving the fas pathway. J. Biol. Chem. 275 (2000) 23807-23813
44. Szakacs G., Annereau J.P., Lababidi S., Shankavaram U., Arciello A., Bussey K.J., Reinhold W., Guo Y., Kruh G.D., Reimers M., Weinstein J.N., and Gottesman M.M. Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell. 6 (2004) 129-137
45. Bergman A.M., Munch-Petersen B., Jensen P.B., Sehested M., Veerman G., Voorn D.A., Smid K., Pinedo H.M., and Peters G.J. Collateral sensitivity to gemcitabine (2′,2′-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines. Biochem. Pharmacol. 61 (2001) 1401-1408
46. Martin-Aragon S., Mukherjee S.K., Taylor B.J., Ivy S.P., Fu C.H., Ardi V.C., and Avramis V.I. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs. Anticancer Res. 20 (2000) 139-150
47. Seo T., Urasaki Y., Takemura H., and Ueda T. Arsenic trioxide circumvents multidrug resistance based on different mechanisms in human leukemia cell lines. Anticancer Res. 25 (2005) 991-998
48. Trompier D., Chang X.B., Barattin R., du Moulinet D'Hardemare A., Di Pietro A., and Baubichon-Cortay H. Verapamil and its derivative trigger apoptosis through glutathione extrusion by multidrug resistance protein MRP1. Cancer Res. 64 (2004) 4950-4956
49. Jonsson-Videsater K., Andersson G., Bergh J., and Paul C. Doxorubicin-resistant, MRP1-expressing U-1285 cells are sensitive to idarubicin. Ther. Drug Monit. 25 (2003) 331-339
50. Bergman A.M., Pinedo H.M., Talianidis I., Veerman G., Loves W.J., van der Wilt C.L., and Peters G.J. Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines. Br. J. Cancer 88 (2003) 1963-1970
51. Laberge R.M., Karwatsky J., Lincoln M.C., Leimanis M.L., and Georges E. Modulation of GSH levels in ABCC1 expressing tumor cells triggers apoptosis through oxidative stress. Biochem. Pharmacol. 73 (2007) 1727-1737
52. Salvayre R., Auge N., Benoist H., and Negre-Salvayre A. Oxidized low-density lipoprotein-induced apoptosis. Biochim. Biophys. Acta 1585 (2002) 213-221
53. Venkateswaran A., Laffitte B.A., Joseph S.B., Mak P.A., Wilpitz D.C., Edwards P.A., and Tontonoz P. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 12097-12102
54. Engel T., Kannenberg F., Fobker M., Nofer J.R., Bode G., Lueken A., Assmann G., and Seedorf U. Expression of ATP binding cassette-transporter ABCG1 prevents cell death by transporting cytotoxic 7beta-hydroxycholesterol. FEBS Lett. 581 (2007) 1673-1680
55. Terasaka N., Wang N., Yvan-Charvet L., and Tall A.R. High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 15093-15098
56. Feng B., Yao P.M., Li Y., Devlin C.M., Zhang D., Harding H.P., Sweeney M., Rong J.X., Kuriakose G., Fisher E.A., Marks A.R., Ron D., and Tabas I. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat. Cell Biol. 5 (2003) 781-792
57. Devries-Seimon T., Li Y., Yao P.M., Stone E., Wang Y., Davis R.J., Flavell R., and Tabas I. Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor. J. Cell Biol. 171 (2005) 61-73
58. Seimon T.A., Obstfeld A., Moore K.J., Golenbock D.T., and Tabas I. Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 19794-19799
59. Bao S., Li Y., Lei X., Wohltmann M., Jin W., Bohrer A., Semenkovich C.F., Ramanadham S., Tabas I., and Turk J. Attenuated free cholesterol loading-induced apoptosis but preserved phospholipid composition of peritoneal macrophages from mice that do not express group VIA phospholipase A2. J. Biol. Chem. 282 (2007) 27100-27114
60. Li Y., Ge M., Ciani L., Kuriakose G., Westover E.J., Dura M., Covey D.F., Freed J.H., Maxfield F.R., Lytton J., and Tabas I. Enrichment of endoplasmic reticulum with cholesterol inhibits sarcoplasmic-endoplasmic reticulum calcium ATPase-2b activity in parallel with increased order of membrane lipids: implications for depletion of endoplasmic reticulum calcium stores and apoptosis in cholesterol-loaded macrophages. J. Biol. Chem. 279 (2004) 37030-37039
61. Li Y., Schwabe R.F., DeVries-Seimon T., Yao P.M., Gerbod-Giannone M.C., Tall A.R., Davis R.J., Flavell R., Brenner D.A., and Tabas I. Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis. J. Biol. Chem. 280 (2005) 21763-21772
62. Feng B., Zhang D., Kuriakose G., Devlin C.M., Kockx M., and Tabas I. Niemann-Pick C heterozygosity confers resistance to lesional necrosis and macrophage apoptosis in murine atherosclerosis. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 10423-10428
63. Tarr P.T., and Edwards P.A. ABCG1 and ABCG4 are coexpressed in neurons and astrocytes of the CNS and regulate cholesterol homeostasis through SREBP-2. J. Lipid Res. 49 (2008) 169-182
64. Janvilisri T., Venter H., Shahi S., Reuter G., Balakrishnan L., and van Veen H.W. Sterol transport by the human breast cancer resistance protein (ABCG2) expressed in Lactococcus lactis. J. Biol. Chem. 278 (2003) 20645-20651
65. Schmitz G., and Langmann T. High-density lipoproteins and ATP-binding cassette transporters as targets for cardiovascular drug therapy. Curr. Opin. Investig. Drugs 6 (2005) 907-919
66. van Vlijmen B.J., Gerritsen G., Franken A.L., Boesten L.S., Kockx M.M., Gijbels M.J., Vierboom M.P., van Eck M., van De Water B., van Berkel T.J., and Havekes L.M. Macrophage p53 deficiency leads to enhanced atherosclerosis in APOE*3-Leiden transgenic mice. Circ. Res. 88 (2001) 780-786
67. Liu J., Thewke D.P., Su Y.R., Linton M.F., Fazio S., and Sinensky M.S. Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 174-179
68. Arai S., Shelton J.M., Chen M., Bradley M.N., Castrillo A., Bookout A.L., Mak P.A., Edwards P.A., Mangelsdorf D.J., Tontonoz P., and Miyazaki T. A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development. Cell. Metab. 1 (2005) 201-213
69. Johnson J.L., Baker A.H., Oka K., Chan L., Newby A.C., Jackson C.L., and George S.J. Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis. Circulation 113 (2006) 2435-2444
70. Baldan A., Pei L., Lee R., Tarr P., Tangirala R.K., Weinstein M.M., Frank J., Li A.C., Tontonoz P., and Edwards P.A. Impaired development of atherosclerosis in hyperlipidemic Ldlr-/- and ApoE-/- mice transplanted with Abcg1-/- bone marrow. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2301-2307
71. Ranalletta M., Wang N., Han S., Yvan-Charvet L., Welch C., and Tall A.R. Decreased atherosclerosis in low-density lipoprotein receptor knockout mice transplanted with Abcg1-/- bone marrow. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2308-2315
72. Out R., Hoekstra M., Hildebrand R.B., Kruit J.K., Meurs I., Li Z., Kuipers F., Van Berkel T.J., and Van Eck M. Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2295-2300
73. Out R., Hoekstra M., Meurs I., de Vos P., Kuiper J., Van Eck M., and Van Berkel T.J. Total body ABCG1 expression protects against early atherosclerotic lesion development in mice. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 594-599
74. Yvan-Charvet L., Ranalletta M., Wang N., Han S., Terasaka N., Li R., Welch C., and Tall A.R. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J. Clin. Invest. 117 (2007) 3900-3908
75. Out R., Hoekstra M., Habets K., Meurs I., de Waard V., Hildebrand R.B., Wang Y., Chimini G., Kuiper J., Van Berkel T.J., and Van Eck M. Combined deletion of macrophage ABCA1 and ABCG1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 258-264
76. Curtiss L.K. Is two out of three enough for ABCG1?. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2175-2177
77. Abildayeva K., Jansen P.J., Hirsch-Reinshagen V., Bloks V.W., Bakker A.H., Ramaekers F.C., de Vente J., Groen A.K., Wellington C.L., Kuipers F., and Mulder M. 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux. J. Biol. Chem. 281 (2006) 12799-12808
78. Karten B., Campenot R.B., Vance D.E., and Vance J.E. Expression of ABCG1, but not ABCA1, correlates with cholesterol release by cerebellar astroglia. J. Biol. Chem. 281 (2006) 4049-4057
79. Hoekstra M., Kruijt J.K., Van Eck M., and Van Berkel T.J. Specific gene expression of ATP-binding cassette transporters and nuclear hormone receptors in rat liver parenchymal, endothelial, and Kupffer cells. J. Biol. Chem. 278 (2003) 25448-25453
80. O'Connell B.J., Denis M., and Genest J. Cellular physiology of cholesterol efflux in vascular endothelial cells. Circulation 110 (2004) 2881-2888
81. Wang N., Yvan-Charvet L., Lutjohann D., Mulder M., Vanmierlo T., Kim T.W., and Tall A.R. ATP-binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain. FASEB J. 22 (2008) 1073-1082